Research ArticleArticle
Open Access
Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling and Eva Baecklund
The Journal of Rheumatology April 2021, jrheum.201251; DOI: https://doi.org/10.3899/jrheum.201251
Johanna Karlsson Sundbaum
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Elizabeth V. Arkema
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Judith Bruchfeld
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Jerker Jonsson
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Johan Askling
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Eva Baecklund
No specific funding was received from any bodies in the public, commercial, or not-for-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum, PhD, Assistant Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, and Department of Health Sciences, Luleå University of Technology, Luleå; E.V. Arkema, PhD, Assistant Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Bruchfeld, PhD, Senior Consultant, Department of Infectious Diseases, Karolinska University Hospital, Stockholm, and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm; J. Jonsson, PhD, Senior Consultant, Public Health Agency of Sweden, Stockholm; J. Askling, PhD, Professor, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, and Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm; E. Baecklund, PhD, Associate Professor, Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. The authors declare no conflicts of interest. Address correspondence to Dr. J. Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden. Email: johanna.sundbaum@ltu.se. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication March 11, 2021.
Article Figures & Data
Additional Files
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling, Eva Baecklund
The Journal of Rheumatology Apr 2021, jrheum.201251; DOI: 10.3899/jrheum.201251
Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling, Eva Baecklund
The Journal of Rheumatology Apr 2021, jrheum.201251; DOI: 10.3899/jrheum.201251